The stock rose almost 6 percent in futures trading on Wall Street after Eli Lilly released its quarterly report.
Eli Lilly expects revenue of $91-92 billion this year, up from its previous forecast of $85-87 billion.
For the third quarter, Eli Lilly reported earnings of $7.48 per share, compared with $7.02 per share in the same quarter last year and an average forecast of $5.59 per share, according to Bloomberg.
Sales rose 39 percent to $24.4 billion, compared with expectations of $22.5 billion.
